Switching to integrase inhibitors from protease inhibitors is associated with new diabetes risk in people with HIV

Diabetes mellitus affects more than 10% of people with HIV, and its incidence is rising as the population ages, according to ...
EurekAlert!

New NIH-funded Johns Hopkins Medicine study finds switching to integrase inhibitors from protease inhibitors is associated with new diabetes risk in people with HIV

In a new Johns Hopkins Medicine study funded by the National Institutes of Health, researchers found adults with HIV who switched from protease inhibitors to integrase inhibitors were at increased ...
Mirage News

HIV Drug Switch Tied to Diabetes Risk: Johns Hopkins Study

Diabetes mellitus affects more than 10% of people with HIV, and its incidence is rising as the population ages, according to ...
Clinical Advisor

Rising Incidence vs Falling Mortality: The Evolving Landscape of Cutaneous Melanoma

Explore the latest statistics on cutaneous melanoma: why incidence rates are rising by 1.2% annually while mortality is ...
Frontiers

Next-Generation Therapeutics for Kidney Disease: From Novel Small Molecules to Targeted Protein Degradation

Chronic kidney disease (CKD) and acute kidney injury (AKI) represent a massive global health burden, affecting millions worldwide and driving a rising ...